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injections of LPS (and after the initial cytokine release) also prevented 
organ injury and death. In contrast, intervention with anti-TNF 
antibody did not provide significant protection. These results support 
the concept that blocking CDl4 in human septic shock may limit 
hypotension, disseminated intravascular coagulation and organ injury 
reculting from cuniulative exposures to LPS. 
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In developed countries, potent combination therapy has led to 
important reductions in morbidity, mortality and hospitalization. 
However, at the same time, as always, we face new challenges. To 
what extent these effects will be sustained is not known. Resources 
and outpatient facilities are being ‘stretched. Poor compliance with 
complicated drug treatments requires a simplification of regimens. 
There is evidence of low-level replication continuing in the face of 
an apparent ‘suppression’ of replication, and together with sanctuary 
sites of virus division, the emergence of resistance in the longer term 
seems inevitable. Resistance may cross drug classes, reducing 
therapeutic options for change. Immune reconstitution is largely 
partial, heightening interest in supplementary immune-based thera- 
pies. Resistance testing is ‘leaking’ into clinical practice before we 
really know how urefuI it is, and when to  start therapy, when to 
change, what to use and how best to sequence drugs are vital 
questions that we need to address. 
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HAART has profoundly affected the incidence of common AIDS- 
related opportunistic infections (01s) in countries where this therapy 
is widely available. In the USA and western Europe, the incidence of 
C X  such as Pnruniocystis carinii pneumonia (PCP), disseminated 
Alyn)/iaiteriuw~ uvinm complex infection (MAC) and cytoniegalovirus 
end-organ disease (CMV) is now 20% of that in 1994. However, the 
incidence does not appear to have decreased further since 1997. 
There have been several recent reports of individual AIDS patients 
with MAC and CMV on  maintenance therapy for these 01s who, 
after their CD4 count rose to 100 cells/(L on HAART, have discon- 
tinued maintenance therapy without 01 relapse after up to 1 year of 
follow-up. There are also reports of small series of patients who were 
receiving PCP or MAC prophylaxis for CD4 counts <?OO or  50 and 
who, aher their CD4 count row to 200 or  lO(1 ceUs/(L on  HAART, 
have discontinued prophylaxis without developing these 0 1 s .  
However, it is not possible to accurately predict which patients with 
prior low CD4 counts who have responded to HAART can safely 
discontinue 01 maintenance or  prophylaxis treatment. Observational 
studies are in progress to better define markers of01 protection. These 
include pathogen-specific immune function and T-cell phenotype 
assays in addition to standard CD4 and I-UV R N A  measurements. 
Pending results of these trials, continued maintenance and pro- 
phylaxis should be based on nadir CD4 counts unless the risk of anti- 
0 1  drug adverse effects is substantial. 
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It is generally assumed that a pool of resittance genes evolved in 
antibiotic-producing microorganisms before antibiotics were u\ed fix 
treatment of infectious diseases. These genes code for antibiotic.- 
inactivating enzymes, like beta-lactamases, as well as target-modif+g 
enzymes like rRNA niethylases. Moreover, efflux pumps reducing 
the intracellular drug concentration have evolved with narrow o r  
broad substrate specificities. The  spread of the corresponding re\i\t- 
ance genes among different bacteria seems to have been primarily 
influenced by the local selective pressure within the natural environ- 
ment. However, during the last decade, conditions of selection have 
changed rapidly due to the intensive use of antibiotics and the 
development of new drugs. But within a short period of time, 
bacteria have developed effective defense mechanisms against every 
new drug introduced. Besides the transfer of preformed reristance 
determinants, point mutations have played a major role in this short- 
term resistance development. These point mutations have affected 
not only genes coding for already existing inactivating enzymes (a‘ i~4 ,  
tila) or regulatory elements controlling efflux pumps (nwz4, mcx), but 
also genes coding for targets of antibiotic action. These include genes 
like rpoB, coding for the target of rifampin, or  genes yyr’4 m d  ynrC,  
coding for the A subunits oftype I1 topoisomerases, DNA gyrase and 
topoisomerase IV, respectively These are the tax-gets inhibited by the 
synthetic quinolones. Due to the high antibacterial activity of new 
fluorinated quinolones against E.  coli, a combination of mutationr is 
required for clinically relevant levels of resirtance. Observations with 
laboratory strains suggest that the accumulation of rerittance muta- 
tions siinultaneously reduces the viability. Thus, additional mutations, 
not necessarily affecting resistance, are aqsumed to restore fitness, a5 
has been observed in fluoroquinolone-resistant clinical isolates. 
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The  discovery of N-acyl-L-homoserine lactone molecules as the 
signaling mechanism in Pliofobmrriuni ( I  ‘ibuio) j s c h e r i  to \en\e m d  
respond to their own density in the light organr of certain fish in 
order to bring about the quorum rerponre of bioluminescence has 
led to the elucidation of similar mechanisms in an ever-increasing 
number of Gram-negative organisms-to the extent that quorum 
sensing appears to be a universal lanpage of Grani-negative bacteria. 
In at least one human pathogen, Psc~~domi~inas erqinosa, quorum 
sensing appears to control the expresion of numerous virulence 
factors such as elastase, exotoxin A, pyocyanin, alkaline proteate, 
cyanide and hemolytin. Interestingly, there even appears to be the 
capability of interspecies communication, with Burkholdcrio ctpacio 
being able to sense and respond to the density of Pseudomunus 
aerqinosa in the lungs of cystic fibrotic patients. Uvng a model bascd 
on the luminescence operon of Photobaiferinm js iheri ,  several poten- 
tial mechanisms to disrupt quorum sensing, and, hence. patho- 
genicity, may be possible. Currently, the most attractive of these i\  t o  
use compounds resembling the n’-acyl-L-honioseriiie lactone 
